Company Overview We are a clinical stage diagnostics company dedicated to improving quality of life and outcomes for the more than 18 million people worldwide who are diagnosed with cancer each year. Our plan is to develop and commercialize a suite of novel genomic tests that support decision making along the entire continuum of oncology care. Our focus will be the launch of our proprietary genomic tests, MSC (MicroRNA Signature Classifier) for patients with lung nodules and StemPrintER for pati...
| Type | Subject | Detail | Quarter |
|---|
| topic_mention | ACUT | discussed_in_filing Cybersecurity | |
| topic_mention | ACUT | discussed_in_filing Trusted Computing | |
| topic_mention | ACUT | discussed_in_filing Blockchain & Crypto | |
| topic_mention | ACUT | discussed_in_filing Regulation | |
| topic_mention | ACUT | discussed_in_filing Healthcare & Bio | |
| topic_mention | ACUT | discussed_in_filing AI Compute | |
| topic_mention | ACUT | discussed_in_filing Platform & Ecosystem | |
| topic_mention | ACUT | discussed_in_filing Sovereign & Government | |
| topic_mention | ACUT | discussed_in_filing Cybersecurity | |
| topic_mention | ACUT | discussed_in_filing Trusted Computing | |
| topic_mention | ACUT | discussed_in_filing Blockchain & Crypto | |
| topic_mention | ACUT | discussed_in_filing Regulation | |
| topic_mention | ACUT | discussed_in_filing Healthcare & Bio | |
| topic_mention | ACUT | discussed_in_filing AI Compute | |
| topic_mention | ACUT | discussed_in_filing Platform & Ecosystem | |
| topic_mention | ACUT | discussed_in_filing Sovereign & Government | |
| topic_mention | ACUT | discussed_in_filing Cybersecurity | |
| topic_mention | ACUT | discussed_in_filing Trusted Computing | |
| topic_mention | ACUT | discussed_in_filing Blockchain & Crypto | |
| topic_mention | ACUT | discussed_in_filing Regulation | |
This is the free public profile. For structured JSON with full provenance chain, use the API: